Targeting dendritic cells to enhance DNA vaccine potency

Cancer Research

Volumn 61, Issue 9, 2001, Pages 3704-3711

  You, Zhaoyang ^a,b   Huang, Xue ^a,b   Hester, Jenny ^a,b   Toh, Han Chong ^a,b   Chen, Si Yi ^a,b  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG POTENCY; ENDOCYTOSIS; FEMALE; HELPER CELL; HEPATITIS B VIRUS; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIBODY FORMATION; ANTIGEN PRESENTATION; B-LYMPHOCYTES; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; HEPATITIS B E ANTIGENS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOTHERAPY, ACTIVE; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, IGG; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TH1 CELLS; VACCINES, DNA;

EID: 0035328668     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. DNA vaccines
2. Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses
3. Antigen presentation by dendritic cells after immunization with DNA encoding a major bistocompatibility complex class II-restricted viral epitope
4. DNA-based immunization by in vivo transfection of dendritic cells
5. Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization
6. Priming of cytotoxic T lymphocytes by DNA vaccines: Requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes
7. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines
8. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells
9. Fc receptors: Rubor redux
10. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor α
11. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization
12. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo
13. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens
14. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules
15. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
16. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen
17. T cell defined tumor antigens
18. Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens
19. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system
20. Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy
21. Immunoblotting and immunodetection
22. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
23. The JAM test. A simple assay for DNA fragmentation and cell death
24. Studies on the Fcγ receptor of the murine macrophage-like cell line P388DI. II. Binding of human IgG subclass proteins and their proteolytic fragments
25. Studies on the Fcγ receptor of the murine macrophage-like cell line P388D1. I. The binding of homologous and heterologous immunoglobulin GI
26. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection
27. Hepatitis B virus gene function: The precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen
28. The hepatitis B virus
29. DNA vaccination: Transfection and activation of dendritic cells as key events for immunity
30. Induction of vigorous helper and cytotoxic T cell as well as B cell responses by DCs expressing a modified antigen targeting receptor-mediated internalization pathway
31. Capture and processing of exogenous antigens for presentation on MHC molecules
32. Mechanisms of antigen uptake for presentation
33. The interaction of particulate horseradish peroxidase (HRP)-anti HRP immune complexes with mouse peritoneal macrophages in vitro
34. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction
35. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge
36. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells
37. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
38. T cell-dependent B cell activation
39. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire
40. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22, 707 men in Taiwan
41. Hepatocellular carcinoma and hepatitis B virus
42. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell response to hepatitis B core and e antigens
43. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection
44. Distinguishing between acute and symptomatic chronic hepatitis B virus infection
45. Serology of acute exacerbation in chronic hepatitis B virus infection
46. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes
47. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice
48. Polyvalent vaccination against hepatitis B surface and core antigen using a dicistronic expression plasmid